Delivery Order SPE2DB24D2101-SPE2DB25FKHQZ

Award Date 3/13/25
Potential Completion Date 4/3/25
Potential Value $8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,915.42 firm fixed-price delivery order contract is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,952.92 firm fixed-price delivery order contract is for the supply of IMFINZI 500 mg/10 ml vials, a specialty oncology medication. The contract has an ultimate completion date of December 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,525.70 firm fixed-price delivery order is for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a performance period ending on January 31, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,830.84, is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a performance period through February 11, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $53,051.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a period of performance through March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $60,233.28 firm fixed-price delivery order is for IMFINZI 500 MG/10 ML VIAL 10ML, with a completion date of July 14, 2023. The contract is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 MG/10 ML VIAL 10ML pharmaceutical products. The $20,560.00 firm-fixed-price contract has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
This is a $7,710 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of IMFINZI 500 MG/10 ML vials, a pharmaceutical product. The order has an ultimate completion date of August 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this delivery order as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through...
This federal contract award, valued at $31,830.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of IMFINZI 500 MG/10 ML VIAL 10ML, with a completion date of February 25, 2025. The contract type is Firm Fixed Price, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMFINZI 500 MG/10 ML VIAL 10ML, a specialty medication, with a ceiling value of $7,976.46. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKHQZ
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,957.71 firm-fixed-price delivery order is for IMFINZI 500 MG/10 ML VIAL 10ML, a pharmaceutical product, with a completion date of April 3, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 6/12/25, 10:20 AM